Literature DB >> 32126019

Insights into the neuropathology of cerebral ischemia and its mechanisms.

Mohamad Anuar Ahad1, Kesevan Rajah Kumaran1,2, Tiang Ning1, Nur Izzati Mansor3,4, Mohamad Azmeer Effendy1, Thenmoly Damodaran1, Kamilla Lingam1, Habibah Abdul Wahab5,6, Norshariza Nordin3,4, Ping Liao7, Christian P Müller8, Zurina Hassan1,6.   

Abstract

Cerebral ischemia is a result of insufficient blood flow to the brain. It leads to limited supply of oxygen and other nutrients to meet metabolic demands. These phenomena lead to brain damage. There are two types of cerebral ischemia: focal and global ischemia. This condition has significant impact on patient's health and health care system requirements. Animal models such as transient occlusion of the middle cerebral artery and permanent occlusion of extracranial vessels have been established to mimic the conditions of the respective type of cerebral ischemia and to further understand pathophysiological mechanisms of these ischemic conditions. It is important to understand the pathophysiology of cerebral ischemia in order to identify therapeutic strategies for prevention and treatment. Here, we review the neuropathologies that are caused by cerebral ischemia and discuss the mechanisms that occur in cerebral ischemia such as reduction of cerebral blood flow, hippocampal damage, white matter lesions, neuronal cell death, cholinergic dysfunction, excitotoxicity, calcium overload, cytotoxic oedema, a decline in adenosine triphosphate (ATP), malfunctioning of Na+/K+-ATPase, and the blood-brain barrier breakdown. Altogether, the information provided can be used to guide therapeutic strategies for cerebral ischemia.

Entities:  

Keywords:  cerebral ischemia; excitotoxicity; neuropathology mechanisms; stroke

Year:  2020        PMID: 32126019     DOI: 10.1515/revneuro-2019-0099

Source DB:  PubMed          Journal:  Rev Neurosci        ISSN: 0334-1763            Impact factor:   4.353


  6 in total

Review 1.  Differential expression of non-coding RNAs and association with cerebral ischemic vascular disorders; diagnostic and therapeutic opportunities.

Authors:  Sharif Alhajlah
Journal:  Genes Genomics       Date:  2022-07-08       Impact factor: 1.839

2.  Clonidine ameliorates cerebral ischemia-reperfusion injury by up-regulating the GluN3 subunits of NMDA receptor.

Authors:  Jing Chen; Juan Zhang; Dan-Dan Yang; Zi-Cheng Li; Bo Zhao; Yue Chen; Zhi He
Journal:  Metab Brain Dis       Date:  2022-06-21       Impact factor: 3.655

3.  Chronic treatment with coenzyme Q10 mitigates the behavioral dysfunction of global cerebral ischemia/reperfusion injury in rats.

Authors:  Iman Fatemi; Pooya Saeed Askari; Elham Hakimizadeh; Ayat Kaeidi; Sogand Esmaeil Moghaddam; Mohammad Pak-Hashemi; Mohammad Allahtavakoli
Journal:  Iran J Basic Med Sci       Date:  2022-01       Impact factor: 2.532

4.  Dynamic Observation of the Effect of L-Theanine on Cerebral Ischemia-Reperfusion Injury Using Magnetic Resonance Imaging under Mathematical Model Analysis.

Authors:  Hui Ye; Zaiming Liu; Long Zhou; Qiang Cai
Journal:  J Healthc Eng       Date:  2021-10-26       Impact factor: 2.682

Review 5.  Antioxidant Therapy in Oxidative Stress-Induced Neurodegenerative Diseases: Role of Nanoparticle-Based Drug Delivery Systems in Clinical Translation.

Authors:  Anushruti Ashok; Syed Suhail Andrabi; Saffar Mansoor; Youzhi Kuang; Brian K Kwon; Vinod Labhasetwar
Journal:  Antioxidants (Basel)       Date:  2022-02-17

Review 6.  LncRNAs Stand as Potent Biomarkers and Therapeutic Targets for Stroke.

Authors:  Junfen Fan; Madeline Saft; Nadia Sadanandan; Bella Gonzales-Portillo; You Jeong Park; Paul R Sanberg; Cesario V Borlongan; Yumin Luo
Journal:  Front Aging Neurosci       Date:  2020-10-19       Impact factor: 5.750

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.